Table: Shin Nippon Biomedical - 6-MTH group results

Shin Nippon Biomedical Laboratories

06/11/2020 06:00

Nov 6 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2020        Sep 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             7.00                6.39             14.81    
                 (+9.6 pct)          (-28.1 pct)      (+1.7 pct)  
  Operating         1.16                1.08              1.80    
                 (+7.7 pct)                           (-19.2 pct) 
  Recurring         1.31                1.26              2.20    
                 (+3.7 pct)          (+42.1 pct)      (-29.5 pct) 
  Net               1.14               877 mln            1.80    
                 (+29.9 pct)         (-3.8 pct)       (-29.4 pct) 
  EPS             27.36 yen           21.07 yen        43.23 yen  
  Ann Div                             5.00 yen         5.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                             5.00 yen         5.00 yen   
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T